Learn about the flu shot, COVID-19 vaccine, and our masking policy »
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Types of Angiogenesis Inhibitors
Types of Angiogenesis Inhibitors
Thalidomide has been identified as having mild activity as an angiogenesis inhibitor in some cancers. A newer version of this medication is lenalidomide (Revlimid), which has fewer side effects than thalidomide.
Another medication, bevacizumab (Avastin®), has been approved by the US Food and Drug Administration (FDA) to aid in the treatment of colorectal, lung, and some other cancers. Two newer additions to antiangiogenesis therapy include sunitinib (Sutent®) and sorafenib (Nexavar®). Many other angiogenesis inhibitors are now being studied as well.
INTERESTED IN AN ONLINE SECOND OPINION?
The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!
Visit our online second opinion page to learn more.
Stanford Cancer Center Palo Alto
Stanford Cancer Center provides a warm, supportive environment that enables patients and families to stay in one location for procedures and tests and focus on healing.Stanford Medicine Cancer Center Palo Alto
875 Blake Wilbur DrivePalo Alto, CA 94304
Phone: 650-498-6000